Table Info

circBase ID	GSE169057	GSE102686
hsa_circ_0000711	4.28e–02	1.57	1.37	7.30e–02
hsa_circ_0000515	3.66e–03	3.75	1.28	4.39e–06
hsa_circ_0001855	2.99e–02	1.79	1.02	4.52e–02

Declarations

Author contributions

MK: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Resources, Validation, Visualization, Writing—original draft, Writing—review & editing.

Conflicts of interest

The author declare that he has no conflicts of interest.

Ethical approval

The study was prepared using publicly available bioinformatics data and does not require ethical approval.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

The datasets generated and analyzed for this study can be found in the GEO (https://www.ncbi.nlm.nih.gov/gds) and TCGA (https://cancergenome.nih.gov/). The author of this publication will provide the raw data to any competent researcher without hesitation.

Funding

Not applicable.

Copyright

References

Sharma S, Deep A, Sharma AK. Current Treatment for Cervical Cancer: An Update. Anticancer Agents Med Chem. 2020;20:1768–79. [DOI] [PubMed]

Vaghasia H, Sakaria S, Prajapati J, Saraf M, Rawal RM. Interactive bioinformatics analysis for the screening of hub genes and molecular docking of phytochemicals present in kitchen spices to inhibit CDK1 in cervical cancer. Comput Biol Med. 2022;149:105994. [DOI] [PubMed]

Yi Y, Liu Y, Wu W, Wu K, Zhang W. Reconstruction and analysis of circRNAmiRNAmRNA network in the pathology of cervical cancer. Oncol Rep. 2019;41:2209–25. [DOI] [PubMed] [PMC]

Liu J, Nie S, Li S, Meng H, Sun R, Yang J, et al. Methylation-driven genes and their prognostic value in cervical squamous cell carcinoma. Ann Transl Med. 2020;8:868. [DOI] [PubMed] [PMC]

Nemeth K, Bayraktar R, Ferracin M, Calin GA. Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet. 2024;25:211–32. [DOI] [PubMed]

Capik O, Sanli F, Kurt A, Ceylan O, Suer I, Kaya M, et al. CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis. Prostate Cancer Prostatic Dis. 2021;24:891–902. [DOI] [PubMed]

Kaya M, Karataş ÖF. The relationship between larynx cancer and microRNAs. Van med J. 2020;27:535–41. [DOI]

Kristensen LS, Jakobsen T, Hager H, Kjems J. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol. 2022;19:188–206. [DOI] [PubMed]

Erdoğan C, Suer İ, Kaya M, Kurt Z, Öztürk Ş, Aydın N, Kurt Z. Bioinformatics analysis of the potentially functional circRNA-miRNA-mRNA network in breast cancer. PLoS One. 2024;19:e0301995. [DOI] [PubMed] [PMC]

10.

Huang W, Wu Y, Qiao M, Xie Z, Cen X, Huang X, et al. CircRNA-miRNA networks in regulating bone disease. J Cell Physiol. 2022;237:1225–44. [DOI] [PubMed]

11.

Zhang M, Bai X, Zeng X, Liu J, Liu F, Zhang Z. circRNA-miRNA-mRNA in breast cancer. Clin Chim Acta. 2021;523:120–30. [DOI] [PubMed]

12.

Erdoğan C, Kaya M, Suer İ. A Bioinformatics Analysis of circRNA/miRNA/mRNA Interactions in Acute Myeloid Leukemia. Experimed. 2023;13:45–53. [DOI]

13.

Shen L, Dang J, Liu S, Xian B, Deng Y, Qu D. CircRNA VPRBP inhibits tumorigenicity of cervical cancer via miR-93-5p/FRMD6 axis. Reprod Sci. 2022;29:2251–64. [DOI] [PubMed]

14.

Song T, Xu A, Chen X, Gao J, Gao F, Kong X. Circular RNA circRNA_101996 promoted cervical cancer development by regulating miR-1236-3p/TRIM37 axis. Kaohsiung J Med Sci. 2021;37:547–61. [DOI] [PubMed]

15.

Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18–27. [DOI] [PubMed] [PMC]

16.

Li R, Qu H, Wang S, Chater JM, Wang X, Cui Y, et al. CancerMIRNome: an interactive analysis and visualization database for miRNome profiles of human cancer. Nucleic Acids Res. 2022;50:D1139–46. [DOI] [PubMed] [PMC]

17.

Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556–60. [DOI] [PubMed] [PMC]

18.

Dudekula DB, Panda AC, Grammatikakis I, De S, Abdelmohsen K, Gorospe M. CircInteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13:34–42. [DOI] [PubMed] [PMC]

19.

Chang L, Zhou G, Soufan O, Xia J. miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res. 2020;48:W244–51. [DOI] [PubMed] [PMC]

20.

Miller HE, Bishop AJR. Correlation AnalyzeR: functional predictions from gene co-expression correlations. BMC Bioinformatics. 2021;22:206. [DOI] [PubMed] [PMC]

21.

Pisignano G, Michael DC, Visal TH, Pirlog R, Ladomery M, Calin GA. Going circular: history, present, and future of circRNAs in cancer. Oncogene. 2023;42:2783–800. [DOI] [PubMed] [PMC]

22.

Kaya M, Suer I, Ozgur E, Capik O, Karatas OF, Ozturk S, et al. miR-145-5p suppresses cell proliferation by targeting IGF1R and NRAS genes in multiple myeloma cells. Turk J Biochem. 2023;48:563–9. [DOI]

23.

Kaya M, Suer İ. The Effect of miR-34a-5p on Overexpressed AML Associated Genes. J Istanb Fac Med. 2023;86:59–68. [DOI]

24.

Suer İ, Kaya M. Is the AURKB Gene Involved in Aml Cell Proliferation Since It is Targeted by miR-34a-5p and let-7b-5p? Konuralp Med J. 2023;15:16–23. [DOI]

25.

Ayaz H, Aslam N, Awan FM, Basri R, Rauff B, Alzahrani B, et al. Mapping CircRNA-miRNA-mRNA regulatory axis identifies hsa_circ_0080942 and hsa_circ_0080135 as a potential theranostic agents for SARS-CoV-2 infection. PLoS One. 2023;18:e0283589. [DOI] [PubMed] [PMC]

26.

Su Q, Lv X. Revealing new landscape of cardiovascular disease through circular RNA-miRNA-mRNA axis. Genomics. 2020;112:1680–5. [DOI] [PubMed]

27.

Rong D, Sun H, Li Z, Liu S, Dong C, Fu K, et al. An emerging function of circRNA-miRNAs-mRNA axis in human diseases. Oncotarget. 2017;8:73271–81. [DOI] [PubMed] [PMC]

28.

Su Y, Yi Y, Li L, Chen C. circRNA-miRNA-mRNA network in age-related macular degeneration: From construction to identification. Exp Eye Res. 2021;203:108427. [DOI] [PubMed]

29.

Tang X, Ren H, Guo M, Qian J, Yang Y, Gu C. Review on circular RNAs and new insights into their roles in cancer. Comput Struct Biotechnol J. 2021;19:910–28. [DOI] [PubMed] [PMC]

30.

Zhi S, Jiang B, Yu W, Li Y, Wang H, Zhou T, et al. Identification of candidate miRNA biomarkers correlated with the prognosis of cell carcinoma and endocervical adenocarcinoma via integrated bioinformatics analysis. Am J Transl Res. 2022;14:8146–55. [PubMed] [PMC]

31.

Gao C, Zhou C, Zhuang J, Liu L, Liu C, Li H, et al. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers. J Cell Biochem. 2018;119:7080–90. [DOI] [PubMed]

32.

Qi Y, Lai Y, Shen P, Chen F, Lin L, Wu H, et al. Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach. Sci Rep. 2020;10:22270. [DOI] [PubMed] [PMC]

33.

Wang W, Luo H, Chang J, Yang X, Zhang X, Zhang Q, et al. Circular RNA circ0001955 promotes cervical cancer tumorigenesis and metastasis via the miR-188-3p/NCAPG2 axis. J Transl Med. 2023;21:356. [DOI] [PubMed] [PMC]

34.

Cao Y, Li J, Jia Y, Zhang R, Shi H. CircRNA circ_POLA2 Promotes Cervical Squamous Cell Carcinoma Progression via Regulating miR-326/GNB1. Front Oncol. 2020;10:959. [DOI] [PubMed] [PMC]

35.

Li J, Ni S, Zhou C, Ye M. The expression profile and clinical application potential of hsa_circ_0000711 in colorectal cancer. Cancer Manag Res. 2018;10:2777–84. [DOI] [PubMed] [PMC]

36.

Chen K, Pan J, Chen Z, Pan D, Gao T, Huang M, et al. Effects of hsa_circ_0000711 expression level on proliferation and apoptosis of hepatoma cells. Eur Rev Med Pharmacol Sci. 2020;24:4161–71. [DOI] [PubMed]

37.

Luan X, Wang Y. LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p. J Gynecol Oncol. 2018;29:e95. [DOI] [PubMed] [PMC]

38.

Meng L, Jia X, Yu W, Wang C, Chen J, Liu F. Circular RNA UBAP2 contributes to tumor growth and metastasis of cervical cancer via modulating miR-361-3p/SOX4 axis. Cancer Cell Int. 2020;20:357. [DOI] [PubMed] [PMC]

39.

Cai F, Fu W, Tang L, Tang J, Sun J, Fu G, et al. Hsa_circ_0000515 is a novel circular RNA implicated in the development of breast cancer through its regulation of the microRNA-296-5p/CXCL10 axis. FEBS J. 2021;288:861–83. [DOI] [PubMed]

40.

Tang Q, Chen Z, Zhao L, Xu H. Circular RNA hsa_circ_0000515 acts as a miR-326 sponge to promote cervical cancer progression through up-regulation of ELK1. Aging (Albany NY). 2019;11:9982–99. [DOI] [PubMed] [PMC]

41.

Jiang M, Lash GE, Zhao X, Long Y, Guo C, Yang H. CircRNA-0004904, CircRNA-0001855, and PAPP-A: Potential Novel Biomarkers for the Prediction of Preeclampsia. Cell Physiol Biochem. 2018;46:2576–86. [DOI] [PubMed]

42.

Yang J, Wan S, Zhao M, Cai H, Gao Y, Wang H. Multi-omics Analysis Identifies Hypoxia Subtypes and S100A2 as an Immunosuppressive Factor in Cervical Cancer. Reprod Sci. 2024;31:107–21. [DOI] [PubMed]

43.

Gao L, Pang Y, Guo X, Zeng J, Tang Z, Xiong D, et al. Polo like kinase 1 expression in cervical cancer tissues generated from multiple detection methods. PeerJ. 2020;8:e10458. [DOI] [PubMed] [PMC]

44.

Lin L, Chuang C, Li C, Liao C, Cheng C, Cheng T, et al. ZBRK1 acts as a metastatic suppressor by directly regulating MMP9 in cervical cancer. Cancer Res. 2010;70:192–201. [DOI] [PubMed] [PMC]

circBase ID	GSE169057		GSE102686
circBase ID	p-value	log2FC	log2FC	p-value
hsa_circ_0000711	4.28e–02	1.57	1.37	7.30e–02
hsa_circ_0000515	3.66e–03	3.75	1.28	4.39e–06
hsa_circ_0001855	2.99e–02	1.79	1.02	4.52e–02